Science - Lantheus Cerveau
Associated imaging, blood chemistry and cognitive assessments are often also archived. Great care is exercised in quality control of these data, and curation is constant. All parties contributing to the Image Core—the Lantheus Cerveau Users Group—have access to …
Press Release - Lantheus Cerveau
Cerveau Technologies Inc. and Prothena Sign Agreement to Provide Novel Tau Imaging Biomarker for Research and Development of Investigational Therapeutics for Neurodegenerative Diseases
Lantheus Cerveau - A novel PET imaging agent for tau in …
At Lantheus Cerveau, our passion is to Find, Fight and Follow ® disease to deliver better patient outcomes. We’re committed to partnering with Alzheimer’s researchers in academia and the pharmaceutical industry.
Contact - Lantheus Cerveau
Contact information 201 Burlington RoadSouth BuildingBedford, MA 01730 Telephone:800-362-2668 Email:[email protected] Leave a message All fields are required. This product candidate is an investigational drug that has not yet been approved as safe and effective.
Form - Lantheus Cerveau
© 2024 Lantheus Cerveau. All rights reserved. 201 Burlington Road, South Building, Bedford, MA 01730 [email protected] • 800-362-2668 PM-US-NP-0067 ...
Publications - Lantheus Cerveau
Kreisl WC, Lao PJ, Johnson A, Tomljanovic Z, Klein J, Polly K, Maas B, Laing KK, Chesebro AG, Igwe K, Razlighi QR, Honig LS, Yan X, Lee S, Mintz A, Luchsinger JA ...
Production Site Login - Lantheus Cerveau
© 2024 Lantheus Cerveau. All rights reserved. 201 Burlington Road, South Building, Bedford, MA 01730 [email protected] • 800-362-2668 PM-US-NP-0067 ...
Lantheus Cerveau
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced it has acquired Knoxville-based Cerveau Technologies, Inc. (“Cerveau”).